Brit J Cancer:吸烟与乳腺癌风险的关系

2021-08-04 MedSci原创 MedSci原创

该MR研究提供了支持证据,表明吸烟者终生吸烟与乳腺癌风险之间存在潜在的因果关系,但每天吸烟量与其无关。

尽管根据最近的流行病学研究报告,吸烟和患乳腺癌风险之间有一定的联系,但吸烟是否与乳腺癌风险之间存在因果关系仍未明确。

近日,肿瘤学领域权威杂志British Journal of Cancer上发表了一篇研究文章,研究人员应用孟德尔随机化(MR)来评估吸烟与乳腺癌风险之间潜在的因果效应。

在终生吸烟指数(LSI)或每天吸烟(CPD)的全基因组关联研究中报告了164个单核苷酸多态性(SNPs)的个体水平数据和汇总统计数据,它们被用于获得MR效应估计值。来自于108420例浸润性乳腺癌患者和87681例对照者的数据被用于LSI分析,并且在26147例癌症患者和26072例对照者中进行了CPD分析。研究人员进行了敏感性分析以解决多效性问题。

吸烟与总体乳腺癌风险的关联

研究人员发现遗传预测的LSI与乳腺癌风险增加相关(每增加一个SD的OR为1.18,95%CI为1.07-1.30,P=0.11×10-2),但没有证据表明遗传预测的CPD与乳腺癌风险增加相关(OR为1.02, 95%CI为0.78-1.19, P=0.85)。敏感性分析得出了类似的结果,并没有强有力的证据表明存在多效性效应。

由此可见,该MR研究提供了支持证据,表明吸烟者终生吸烟与乳腺癌风险之间存在潜在的因果关系,但每天吸烟量与其无关。

原始出处:

Hanla A. Park.et al.Mendelian randomisation study of smoking exposure in relation to breast cancer risk.Brit J Cancer.2021.https://www.nature.com/articles/s41416-021-01432-8

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2062030, encodeId=b1f820620301b, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Fri Sep 10 10:52:49 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204283, encodeId=c5c0120428364, content=<a href='/topic/show?id=13c5394250a' target=_blank style='color:#2F92EE;'>#吸烟#</a>与<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39425, encryptionId=13c5394250a, topicName=吸烟), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Mar 20 10:23:14 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770341, encodeId=24ca1e70341e6, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Fri Jun 17 22:52:49 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820474, encodeId=a62318204e414, content=<a href='/topic/show?id=c87f10089032' target=_blank style='color:#2F92EE;'>#风险的关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100890, encryptionId=c87f10089032, topicName=风险的关系)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Wed Apr 06 08:52:49 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
    2021-09-10 sjq027
  2. [GetPortalCommentsPageByObjectIdResponse(id=2062030, encodeId=b1f820620301b, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Fri Sep 10 10:52:49 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204283, encodeId=c5c0120428364, content=<a href='/topic/show?id=13c5394250a' target=_blank style='color:#2F92EE;'>#吸烟#</a>与<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39425, encryptionId=13c5394250a, topicName=吸烟), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Mar 20 10:23:14 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770341, encodeId=24ca1e70341e6, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Fri Jun 17 22:52:49 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820474, encodeId=a62318204e414, content=<a href='/topic/show?id=c87f10089032' target=_blank style='color:#2F92EE;'>#风险的关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100890, encryptionId=c87f10089032, topicName=风险的关系)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Wed Apr 06 08:52:49 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2062030, encodeId=b1f820620301b, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Fri Sep 10 10:52:49 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204283, encodeId=c5c0120428364, content=<a href='/topic/show?id=13c5394250a' target=_blank style='color:#2F92EE;'>#吸烟#</a>与<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39425, encryptionId=13c5394250a, topicName=吸烟), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Mar 20 10:23:14 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770341, encodeId=24ca1e70341e6, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Fri Jun 17 22:52:49 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820474, encodeId=a62318204e414, content=<a href='/topic/show?id=c87f10089032' target=_blank style='color:#2F92EE;'>#风险的关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100890, encryptionId=c87f10089032, topicName=风险的关系)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Wed Apr 06 08:52:49 CST 2022, time=2022-04-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2062030, encodeId=b1f820620301b, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Fri Sep 10 10:52:49 CST 2021, time=2021-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204283, encodeId=c5c0120428364, content=<a href='/topic/show?id=13c5394250a' target=_blank style='color:#2F92EE;'>#吸烟#</a>与<a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39425, encryptionId=13c5394250a, topicName=吸烟), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Sun Mar 20 10:23:14 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770341, encodeId=24ca1e70341e6, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Fri Jun 17 22:52:49 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1820474, encodeId=a62318204e414, content=<a href='/topic/show?id=c87f10089032' target=_blank style='color:#2F92EE;'>#风险的关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100890, encryptionId=c87f10089032, topicName=风险的关系)], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/cc81592b507031e3cfd8d4c57911d98b/62c22832a9474aea1ca90ca058aebc03.jpg, createdBy=bed5446, createdName=limedical1974, createdTime=Wed Apr 06 08:52:49 CST 2022, time=2022-04-06, status=1, ipAttribution=)]

相关资讯

JNCCN:女性乳腺癌患者既往接受钼靶筛查对预后的影响

JNCCN:女性乳腺癌患者既往接受钼靶筛查对预后的影响

NEJM:绝经后乳腺癌患者采用芳香化酶抑制剂辅助治疗时间多长为宜?

在接受5年辅助内分泌治疗的激素受体阳性乳腺癌绝经女性中,将激素治疗延长5年与延长2年相比没有任何益处,但骨折风险更大。

Radiology:对乳腺癌幸存者来说,钼靶筛查已远远不够

早期筛查和先进的治疗方案降低了乳腺癌妇女的死亡率。因此,全世界乳腺癌幸存者的数量正在增加,现阶段在美国已有估计380万乳腺癌幸存者。

Science Translational Medicine:击败耐药性,根除癌细胞!无复发、无转移的乳腺癌新药重磅出炉

乳腺癌,女性头号健康杀手,在全球女性中的发病率和死亡率均列恶性肿瘤第一位。在乳腺癌患者中,约75%患有雌激素受体α(estrogen receptorα,ERα)阳

Radiology:并非技术越复杂结果越理想!乳腺MRI有话说

乳腺增强MRI对检测其他隐匿性乳腺癌具有极高的敏感性,但其作为补充筛查工具时的主要局限性是假阳率较高,进一步导致不必要的活检及手术。

JCO:梅奥建议,65 岁以上女性应进行遗传性癌症基因检测

美国NCCN指南建议,对于大于65岁的女性,如果没有特定的风险因素,乳腺癌相关基因突变较低,因此遗传性癌症检测的临床效用有限。